Global Fetal Bovine Serum Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Fetal Bovine Serum Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Fetal bovine serum is the remained blood fraction after the natural coagulation of blood, which is obtained by centrifugation to remove any remaining red blood cells.

Fetal bovine serum is a kind of serum obtained from fetal bovine by stabbing the hearts and collecting the bloods when slaughtering pregnant cows.

Market Overview:

The latest research study on the global Fetal Bovine Serum market finds that the global Fetal Bovine Serum market reached a value of USD 851.89 million in 2022. It’s expected that the market will achieve USD 1316.2 million by 2028, exhibiting a CAGR of 7.52% during the forecast period.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

Thermo Fisheris one of the major players operating in the Fetal Bovine Serum market, holding a share of 26.08% in 2018.

Thermo Fisher Scientific is an American multinational, biotechnology product development company, created in 2006 by the merger of Thermo Electron and Fisher Scientific.

Thermo Fisher acquired Life Technologies Corp for $13.6 billion in a deal that would rank the firm as one of the leading companies in the genetic testing and precision laboratory equipment markets. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs, manufactures and delivers technologies used in bioprocessing solutions. In June 2015, the company announced its intention to acquire Alfa Aesar, a global manufacturer of research chemicals for $405 million from Johnson Matthey, and the acquisition was completed at the end of september.

GE Healthcare is a subsidiary of General Electric (GE), headquartered in Little Chalfont, Buckinghamshire, United Kingdom. The company provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies and performance solutions services.

Segmentation Overview:

By type, North America-sourced segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Scientific Research segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Fetal Bovine Serum market covered in Chapter 3:

Biological Industries
Internegocios
Atlanta Biologicals
RMBIO
GE Healthcare
Bio Nutrientes Brasil
Jin Yuan Kang
Merck
Bovogen
Zhejiang Tianhang Biotechnology
ExCell Bio
Corning
Thermo Fisher
Seroxlab
Tissue Culture Biologicals
Moregate BioTech
Gemini
NorthBio
Lanzhou Minhai
Biowest
PAN-Biotec
Peak Serum
Serana
WISENT

In Chapter 4 and Chapter 14.2, on the basis of types, the Fetal Bovine Serum market from 2018 to 2029 is primarily split into:

North America-sourced
South America-sourced
Australia-sourced

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Fetal Bovine Serum market from 2018 to 2029 covers:

Scientific Research
Industrial Production

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)